Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan

Details 詳細情報について

• CRID

  1360009142413289472

• DOI

  10.1016/j.rmed.2018.06.021

• ISSN

  09546111

• Web Site

  https://api.elsevier.com/content/article/PII:S0954611118302191?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0954611118302191?httpAccept=text/plain

• Data Source

  • Crossref
  • KAKEN